{"created_at":"Thu Feb 19 22:58:10 +0000 2015","id":568545104635383808,"id_str":"568545104635383808","text":"RT @FiercePharma: FDA grants Celgene's Revlimid new use as it moves toward $10B in sales http:\/\/t.co\/2lS9j8eLR2 $CELG #pharma by @EricPFier\u2026","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":254397874,"id_str":"254397874","name":"\u3068\u3080\u3075\u3049\u30fc\u3069\uff13\uff18","screen_name":"tomford38","location":"","url":null,"description":"\u500b\u4eba\u6295\u8cc7\u5bb6\u3002\u5c02\u696d\u3002\u65e5\u672c\u682a\u3001\u7c73\u56fd\u682a\u3002\n\u682a\u5f0f\u5e02\u5834\u306b\u306f\u6bce\u65e5\u53c2\u52a0\u3002\u52d5\u3044\u3066\u308b\u9298\u67c4\u3064\u3076\u3084\u304d\u307e\u3059\u304c\u30c7\u30a4\u30c8\u30ec\u5c11\u306a\u3044\u3067\u3059\u3002\n\u4fdd\u6709\u3057\u3066\u308b\u9298\u67c4\u3001\u30c8\u30ec\u30fc\u30c9\u6210\u7e3e\u306b\u3064\u3044\u3066\u306f\u3001\u307b\u307c\u30c4\u30a4\u30fc\u30c8\u3057\u306a\u3044\u3002\n\n\u30cd\u30b3\u30fb\u30d5\u30a1\u30c3\u30b7\u30e7\u30f3\u30fb\u30a4\u30bf\u30ea\u30a2\u30fb\u30b5\u30c3\u30ab\u30fc\u30fb\u65c5\u884c\u3068\u304b\u597d\u304d","protected":false,"verified":false,"followers_count":1769,"friends_count":1735,"listed_count":85,"favourites_count":306,"statuses_count":92676,"created_at":"Sat Feb 19 05:40:18 +0000 2011","utc_offset":32400,"time_zone":"Tokyo","geo_enabled":false,"lang":"ja","contributors_enabled":false,"is_translator":false,"profile_background_color":"0099B9","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/760314970\/0396571531c86c54fde9b5a25f5a01b7.jpeg","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/760314970\/0396571531c86c54fde9b5a25f5a01b7.jpeg","profile_background_tile":true,"profile_link_color":"0099B9","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"95E8EC","profile_text_color":"3C3940","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/1282904868\/11-01-09_1204_normal.jpg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/1282904868\/11-01-09_1204_normal.jpg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/254397874\/1383365978","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Thu Feb 19 17:27:12 +0000 2015","id":568461812523356161,"id_str":"568461812523356161","text":"FDA grants Celgene's Revlimid new use as it moves toward $10B in sales http:\/\/t.co\/2lS9j8eLR2 $CELG #pharma by @EricPFierce","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":18294275,"id_str":"18294275","name":"FiercePharma","screen_name":"FiercePharma","location":"West End, District of Columbia","url":"http:\/\/www.fiercepharma.com","description":"FiercePharma's 140, written by Tracy Staton. Join 90,000 pharma insiders on our free newsletter at http:\/\/FiercePharma.com.","protected":false,"verified":false,"followers_count":38223,"friends_count":463,"listed_count":1159,"favourites_count":9,"statuses_count":16551,"created_at":"Sun Dec 21 22:25:49 +0000 2008","utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"060932","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"DA490B","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"DDFFCC","profile_text_color":"080707","profile_use_background_image":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/2579243072\/qooxzvtqfq9bj6kkhllk_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/2579243072\/qooxzvtqfq9bj6kkhllk_normal.jpeg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":3,"favorite_count":0,"entities":{"hashtags":[{"text":"pharma","indices":[100,107]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/2lS9j8eLR2","expanded_url":"http:\/\/www.fiercepharma.com\/story\/fda-grants-celgenes-revlimid-new-use-it-moves-toward-10b-sales\/2015-02-19","display_url":"fiercepharma.com\/story\/fda-gran\u2026","indices":[71,93]}],"user_mentions":[{"screen_name":"EricPFierce","name":"Eric Palmer","id":479884627,"id_str":"479884627","indices":[111,123]}],"symbols":[{"text":"CELG","indices":[94,99]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"pharma","indices":[118,125]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/2lS9j8eLR2","expanded_url":"http:\/\/www.fiercepharma.com\/story\/fda-grants-celgenes-revlimid-new-use-it-moves-toward-10b-sales\/2015-02-19","display_url":"fiercepharma.com\/story\/fda-gran\u2026","indices":[89,111]}],"user_mentions":[{"screen_name":"FiercePharma","name":"FiercePharma","id":18294275,"id_str":"18294275","indices":[3,16]},{"screen_name":"EricPFierce","name":"Eric Palmer","id":479884627,"id_str":"479884627","indices":[139,140]}],"symbols":[{"text":"CELG","indices":[112,117]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1424386690659"}
{"created_at":"Fri Feb 20 17:22:47 +0000 2015","id":568823090517385216,"id_str":"568823090517385216","text":"RT @dougheuringaria: @pharmamaven amazing run you had over the last year $CELG $ACAD $TGTX $ZIOP $CRMD $ZIOP $OMED on and on. Again big THA\u2026","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":243795494,"id_str":"243795494","name":"rc","screen_name":"pharmamaven","location":"","url":null,"description":"Long term biotech investor, ex CEO\/CFO of large financial co's, Springsteen,Yankee & NY Giant fan. Love Italy, Hawaii, the beach and playing craps with friends.","protected":false,"verified":false,"followers_count":748,"friends_count":63,"listed_count":22,"favourites_count":595,"statuses_count":3494,"created_at":"Thu Jan 27 20:48:15 +0000 2011","utc_offset":-32400,"time_zone":"Alaska","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/1786305973\/Balboa_normal.jpg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/1786305973\/Balboa_normal.jpg","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Fri Feb 20 17:09:20 +0000 2015","id":568819704543850496,"id_str":"568819704543850496","text":"@pharmamaven amazing run you had over the last year $CELG $ACAD $TGTX $ZIOP $CRMD $ZIOP $OMED on and on. Again big THANK YOU for your effort","source":"\u003ca href=\"http:\/\/twitter.com\/download\/iphone\" rel=\"nofollow\"\u003eTwitter for iPhone\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":568815710924722176,"in_reply_to_status_id_str":"568815710924722176","in_reply_to_user_id":122134262,"in_reply_to_user_id_str":"122134262","in_reply_to_screen_name":"dougheuringaria","user":{"id":122134262,"id_str":"122134262","name":"dougheuring","screen_name":"dougheuringaria","location":"mo","url":null,"description":"Investor that likes to help others out. Fulltime Family man. Loves sports &Biotechs are his passion","protected":false,"verified":false,"followers_count":1686,"friends_count":615,"listed_count":54,"favourites_count":4440,"statuses_count":5470,"created_at":"Thu Mar 11 18:12:55 +0000 2010","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/553769556343525376\/bEjkV1Rz_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/553769556343525376\/bEjkV1Rz_normal.jpeg","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":1,"favorite_count":1,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[{"screen_name":"pharmamaven","name":"rc","id":243795494,"id_str":"243795494","indices":[0,12]}],"symbols":[{"text":"CELG","indices":[52,57]},{"text":"ACAD","indices":[58,63]},{"text":"TGTX","indices":[64,69]},{"text":"ZIOP","indices":[70,75]},{"text":"CRMD","indices":[76,81]},{"text":"ZIOP","indices":[82,87]},{"text":"OMED","indices":[88,93]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[{"screen_name":"dougheuringaria","name":"dougheuring","id":122134262,"id_str":"122134262","indices":[3,19]},{"screen_name":"pharmamaven","name":"rc","id":243795494,"id_str":"243795494","indices":[21,33]}],"symbols":[{"text":"CELG","indices":[73,78]},{"text":"ACAD","indices":[79,84]},{"text":"TGTX","indices":[85,90]},{"text":"ZIOP","indices":[91,96]},{"text":"CRMD","indices":[97,102]},{"text":"ZIOP","indices":[103,108]},{"text":"OMED","indices":[109,114]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1424452967658"}
{"created_at":"Fri Feb 20 17:55:26 +0000 2015","id":568831307167498240,"id_str":"568831307167498240","text":"RT @AndyBiotech: $CELG\/Inhibrx anti-CD47 mAb CC-90002 PhI trial finally posted\nhttp:\/\/t.co\/zUEIcYV2kz (N=100) $TRIL","source":"\u003ca href=\"http:\/\/twitter.com\/download\/android\" rel=\"nofollow\"\u003eTwitter for Android\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":30820266,"id_str":"30820266","name":"Joshua B","screen_name":"srqstockpicker","location":"","url":null,"description":"Biotech enthusiast and master googler lol  Do your own Due Diligence!  Personal posts as well.","protected":false,"verified":false,"followers_count":804,"friends_count":859,"listed_count":22,"favourites_count":6679,"statuses_count":9113,"created_at":"Mon Apr 13 06:18:51 +0000 2009","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/489204640123076608\/ZLqT9NJS_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/489204640123076608\/ZLqT9NJS_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/30820266\/1408243196","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Fri Feb 20 17:23:17 +0000 2015","id":568823217294577664,"id_str":"568823217294577664","text":"$CELG\/Inhibrx anti-CD47 mAb CC-90002 PhI trial finally posted\nhttp:\/\/t.co\/zUEIcYV2kz (N=100) $TRIL","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":510168740550680576,"in_reply_to_status_id_str":"510168740550680576","in_reply_to_user_id":632341632,"in_reply_to_user_id_str":"632341632","in_reply_to_screen_name":"AndyBiotech","user":{"id":632341632,"id_str":"632341632","name":"Andy Biotech","screen_name":"AndyBiotech","location":"","url":null,"description":"#Biotech Investor | Recovering Scientist | #RareDiseases Advocate | May have positions in mentioned names | Opinions are strictly my own","protected":false,"verified":false,"followers_count":10053,"friends_count":481,"listed_count":296,"favourites_count":3988,"statuses_count":11471,"created_at":"Tue Jul 10 19:50:09 +0000 2012","utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C6E2EE","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme2\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme2\/bg.gif","profile_background_tile":false,"profile_link_color":"1F98C7","profile_sidebar_border_color":"C6E2EE","profile_sidebar_fill_color":"DAECF4","profile_text_color":"663B12","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/378800000074240482\/d961ebeb9f4fe6b084a68663b9a36738_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/378800000074240482\/d961ebeb9f4fe6b084a68663b9a36738_normal.png","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":9,"favorite_count":6,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/zUEIcYV2kz","expanded_url":"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02367196","display_url":"clinicaltrials.gov\/ct2\/show\/NCT02\u2026","indices":[62,84]}],"user_mentions":[],"symbols":[{"text":"CELG","indices":[0,5]},{"text":"TRIL","indices":[93,98]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/zUEIcYV2kz","expanded_url":"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02367196","display_url":"clinicaltrials.gov\/ct2\/show\/NCT02\u2026","indices":[79,101]}],"user_mentions":[{"screen_name":"AndyBiotech","name":"Andy Biotech","id":632341632,"id_str":"632341632","indices":[3,15]}],"symbols":[{"text":"CELG","indices":[17,22]},{"text":"TRIL","indices":[110,115]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1424454926660"}
{"created_at":"Fri Feb 20 13:44:08 +0000 2015","id":568768065439051776,"id_str":"568768065439051776","text":"Celgene's REVLIMID approved by the European Commission for treatment of adults with untreated multiple myeloma. ($CELG)","source":"\u003ca href=\"http:\/\/stocktwits.com\" rel=\"nofollow\"\u003eStockTwits Web\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":495660523,"id_str":"495660523","name":"TopFlight Trades","screen_name":"TopFlightTrades","location":"","url":"http:\/\/www.topflighttrades.com","description":null,"protected":false,"verified":false,"followers_count":1107,"friends_count":1990,"listed_count":8,"favourites_count":209,"statuses_count":1528,"created_at":"Sat Feb 18 05:49:29 +0000 2012","utc_offset":-28800,"time_zone":"Pacific Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"022330","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme15\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme15\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"A8C7F7","profile_sidebar_fill_color":"C0DFEC","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/564999774558900224\/QwFrYo0L_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/564999774558900224\/QwFrYo0L_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/495660523\/1423929038","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[],"symbols":[]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1424439848657"}
